Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01926873 · ClinicalTrials.gov registry record
A Screening Study To Assess The Cognition Status in Healthy Volunteers
A clinical trial of Healthy Volunteer, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- 240
- Enrollment target
- 12
- Study locations
NCT01926873 is a study of Healthy Volunteer that has completed, run by Hoffmann-La Roche. The registered enrollment target is 240 participants, above the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (20% higher). The trial reports 12 study locations across 6 states.
The verdict
NCT01926873, a study of Healthy Volunteer, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
- 12
- Study locations
Study Summary
This multi-center screening study will conduct a cognition assessment to collect reference data for comparison to patients with depression in healthy volunteers. Data will be collected for 6 weeks.
Conditions Studied
Study Locations (12)
Other
- - Freiburg im Breisgau
- - Mainz
- - Mannheim
- - Schwerin, Mecklenburg-Vorpommern
- - Bialystok
- - Choroszcz
- - Tuszyn
California
- - San Diego
Georgia
- - Atlanta
Illinois
- - Oak Brook
New York
- - Cedarhurst
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01926873
The ClinicalTrials.gov registry entry for NCT01926873 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 200-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (20% higher). The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteer appearing as the primary indexed condition, and to 0 interventions.
NCT01926873 reports 12 study locations spanning 6 distinct geographic areas - top geographies include Other, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT01926873 about?
NCT01926873 is a clinical study titled "A Screening Study To Assess The Cognition Status in Healthy Volunteers". This multi-center screening study will conduct a cognition assessment to collect reference data for comparison to patients with depression in healthy volunteers. Data will be collected for 6 weeks.
What is the current status of trial NCT01926873?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2013-08. Estimated completion is 2014-07.
What conditions does trial NCT01926873 study?
This clinical trial studies the following conditions: Healthy Volunteer.
Who is sponsoring clinical trial NCT01926873?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01926873 being conducted?
This trial has 12 study locations across California, Georgia, Illinois, New York, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Healthy Volunteer Study
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
RECRUITING · Phase 1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
RECRUITING · Phase 1
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.